Poolbeg Pharma PLC (POLB.L)
GBp 3.05
(-6.15%)
GBp 3.05
(-6.15%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -3.93 Million GBP | 16.11% |
| 2022 | -4.68 Million GBP | -100.6% |
| 2021 | -2.33 Million GBP | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -1.12 Million GBP | -100.0% |
| 2024 Q1 | -1.12 Million GBP | 46.75% |
| 2023 Q3 | -1.06 Million GBP | 41.47% |
| 2023 FY | -3.93 Million GBP | 16.11% |
| 2023 Q1 | -905.5 Thousand GBP | 70.59% |
| 2023 Q2 | -1.81 Million GBP | -100.0% |
| 2023 Q4 | -2.12 Million GBP | -100.0% |
| 2022 Q2 | -1.6 Million GBP | -100.0% |
| 2022 FY | -4.68 Million GBP | -100.6% |
| 2022 Q4 | -3.07 Million GBP | -100.0% |
| 2022 Q3 | -1.53 Million GBP | 4.2% |
| 2022 Q1 | -803.5 Thousand GBP | 0.0% |
| 2021 FY | -2.33 Million GBP | 0.0% |
| Name | Net Income | Net Income Difference |
|---|